Terms: = Lung cancer AND RHOH, TTF, 399, ENSG00000168421, ARHH, RhoH AND Prognosis
201 results:
1. Biphenotypic lung carcinoma with coexpression of ttf-1 and ΔNP63/P40 within most of the same individual cells: a further case confirming poor prognosis and a review of literature.
Marando A; Zagni M; Negrelli M; Valtorta E; Lauricella C; Motta V; Veronese S; Cerea G; Giannetta LG; Ciarlo G; Signorelli D; Pizzutilo EG; Bonoldi E; Pelosi G
Pathologica; 2024 Feb; 116(1):13-21. PubMed ID: 38482671
[TBL] [Abstract] [Full Text] [Related]
2. Association of Nutritional Indices With Adverse Effects and Time-to-Treatment-Failure in Triple Therapy for lung cancer.
Hashino Y; Matushita T; Hatsuyama T; Wakamoto A; Goto K; Hoshi T; Iwayama K; Ohtaki K; Toda T; Sato H
In Vivo; 2024; 38(2):864-872. PubMed ID: 38418111
[TBL] [Abstract] [Full Text] [Related]
3. Lack of imbalance between the master regulators ttf1/NKX2-1 and ΔNp63/p40 implies adverse prognosis in non-small cell lung cancer.
Vescio M; Bulloni M; Pelosi G; Pattini L
Sci Rep; 2024 Jan; 14(1):2467. PubMed ID: 38291083
[TBL] [Abstract] [Full Text] [Related]
4. Association of Geriatric Nutritional Risk Index With Immune Checkpoint Inhibitor Treatment Duration and Adverse Events in lung cancer.
Shimizu A; Fukasawa M; Mitani K; Goto K; Wakamoto A; Hatsuyama T; Hoshi T; Hasegawa I; Sato H
In Vivo; 2024; 38(1):418-424. PubMed ID: 38148096
[TBL] [Abstract] [Full Text] [Related]
5. ttf-1 status in early-stage lung adenocarcinoma is an independent predictor of relapse and survival superior to tumor grading.
Schallenberg S; Dernbach G; Dragomir MP; Schlachtenberger G; Boschung K; Friedrich C; Standvoss K; Ruff L; Anders P; Grohé C; Randerath W; Merkelbach-Bruse S; Quaas A; Heldwein M; Keilholz U; Hekmat JK; Rückert C; Büttner R; Horst D; Klauschen F; Frost N
Eur J Cancer; 2024 Jan; 197():113474. PubMed ID: 38100920
[TBL] [Abstract] [Full Text] [Related]
6. Different effects of crizotinib treatment in two non-small cell lung cancer patients with SDC4::ROS1 fusion variants.
Ohishi Y; Nakanishi Y; Hirotani Y; Suzuki A; Tanino T; Nishimaki-Watanabe H; Kobayashi H; Nozaki F; Ohni S; Tang X; Hayashi K; Nakagawa Y; Shimizu T; Tsujino I; Takahashi N; Gon Y; Masuda S
Thorac Cancer; 2024 Jan; 15(1):89-93. PubMed ID: 38093515
[TBL] [Abstract] [Full Text] [Related]
7. Extracranial malignant rhabdoid tumors in children: high mortality even with the help of an aggressive clinical approach.
Xie S; Fang Y; Yang Y; Liu L; Bai J; Lin S; Zhang B; Fang Y
Eur J Pediatr; 2024 Feb; 183(2):557-567. PubMed ID: 38019286
[TBL] [Abstract] [Full Text] [Related]
8. POU2F3-Expressing Small Cell lung Carcinoma and Large Cell Neuroendocrine Carcinoma Show Morphologic and Phenotypic Overlap.
Jimbo N; Ohbayashi C; Takeda M; Fujii T; Mitsui S; Tsukamoto R; Tanaka Y; Itoh T; Maniwa Y
Am J Surg Pathol; 2024 Jan; 48(1):4-15. PubMed ID: 37904277
[TBL] [Abstract] [Full Text] [Related]
9. The clinicopathological features of BRG1-deficient non-small cell lung cancer and its response to immunotherapy: A single-center retrospective study.
Zhang J; Zhao R; Xu H; Dong L; Chen X
Ann Diagn Pathol; 2023 Dec; 67():152192. PubMed ID: 37639838
[TBL] [Abstract] [Full Text] [Related]
10. Clinicopathological features and differential diagnosis of gastric metastases.
Chen W; Liu C; Liu Y; Yuan J; Wang Z
World J Surg Oncol; 2023 Aug; 21(1):258. PubMed ID: 37608278
[TBL] [Abstract] [Full Text] [Related]
11. Continuous vs. Fixed 2-year Duration Immune Checkpoint Inhibitor Treatment of Patients With Non-Small Cell lung cancer: A Single Institution Database Analysis.
Kobayashi H; Wakuda K; Naito T; Mamesaya N; Ko R; Ono A; Kenmotsu H; Murakami H; Shimizu T; Gon Y; Takahashi T
Clin Lung Cancer; 2023 Sep; 24(6):498-506.e3. PubMed ID: 37407292
[TBL] [Abstract] [Full Text] [Related]
12. A case report of pulmonary hepatoid adenocarcinoma: promoting standardized diagnosis and treatment of the rare disease.
Xu K; Gao J; Feng L; Fang Y; Tang X
Front Immunol; 2023; 14():1203876. PubMed ID: 37292208
[TBL] [Abstract] [Full Text] [Related]
13. Upfront Use of First-/Second-Generation EGFR-TKI Followed by Osimertinib Shows Better prognosis than Upfront Osimertinib Therapy in Japanese Patients with Non-small-cell lung cancer with Exon 19 Deletion: A Single-Center Retrospective Study.
Hori T; Yamamoto K; Ito T; Ikushima S; Omura T; Yano I
Biol Pharm Bull; 2023; 46(6):788-795. PubMed ID: 37258143
[TBL] [Abstract] [Full Text] [Related]
14. Clinical characteristics and prognostic analysis of SMARCA4-deficient non-small cell lung cancer.
Liang X; Gao X; Wang F; Li S; Zhou Y; Guo P; Meng Y; Lu T
Cancer Med; 2023 Jul; 12(13):14171-14182. PubMed ID: 37184108
[TBL] [Abstract] [Full Text] [Related]
15. Metastases to the kidney from primary lung cancer : clinicopathological analysis of six cases in a single center.
Lian H; Pan X; Hong B; Min J; Huang F
Diagn Pathol; 2023 May; 18(1):60. PubMed ID: 37161448
[TBL] [Abstract] [Full Text] [Related]
16. Multi-omics analysis unravels the underlying mechanisms of poor prognosis and differential therapeutic responses of solid predominant lung adenocarcinoma.
Li F; Wang S; Wang Y; Lv Z; Jin D; Yi H; Fu L; Zhai S; Xiao T; Mao Y
Front Immunol; 2023; 14():1101649. PubMed ID: 36845145
[TBL] [Abstract] [Full Text] [Related]
17. Deep learning model integrating positron emission tomography and clinical data for prognosis prediction in non-small cell lung cancer patients.
Oh S; Kang SR; Oh IJ; Kim MS
BMC Bioinformatics; 2023 Feb; 24(1):39. PubMed ID: 36747153
[TBL] [Abstract] [Full Text] [Related]
18. Relationship between brain metastasis and thyroid transcription factor 1.
Kut E; Menekşe S
Sci Rep; 2023 Feb; 13(1):1945. PubMed ID: 36732655
[TBL] [Abstract] [Full Text] [Related]
19. Ascl1 and OTP tumour expressions are associated with disease-free survival in lung atypical carcinoids.
Centonze G; Maisonneuve P; Simbolo M; Lagano V; Grillo F; Prinzi N; Pusceddu S; Missiato L; Colantuono M; Sabella G; Bercich L; Mangogna A; Rolli L; Grisanti S; Benvenuti MR; Pastorino U; Roz L; Scarpa A; Berruti A; Capella C; Milione M
Histopathology; 2023 May; 82(6):870-884. PubMed ID: 36720841
[TBL] [Abstract] [Full Text] [Related]
20. Prognostic prediction of lung adenocarcinoma by integrative analysis of 399FF">rhoh expression and methylation.
Kuang M; Zhou Z; Lu Z; Shen W; Ge H; Tao X; Zhao Y; Zhuge L; Sun Y; Ji D; Zhang H
Clin Respir J; 2023 Mar; 17(3):148-156. PubMed ID: 36710485
[TBL] [Abstract] [Full Text] [Related]
[Next]
